Found: 20
Select item for more details and to access through your institution.
1558. A Population Pharmacokinetic Model for Posaconazole Intravenous Solution and Oral Powder for Suspension Formulations in Pediatric Patients With Neutropenia.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S569, doi. 10.1093/ofid/ofz360.1422
- By:
- Publication type:
- Article
Pediatric oncology drug development and dosage optimization.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1235947
- By:
- Publication type:
- Article
Development and application of a mathematical model of modulation of cerebrospinal fluid Aβ40 after treatment with gamma- and beta-secretase inhibitors
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Population PK and Semimechanistic PK/PD Modeling and Simulation of Relugolix Effects on Testosterone Suppression in Men with Prostate Cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 124, doi. 10.1002/cpt.2743
- By:
- Publication type:
- Article
Characterizing the exposure–response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 11, p. 1687, doi. 10.1002/psp4.12922
- By:
- Publication type:
- Article
Model‐based meta‐analysis of non‐small cell lung cancer with standard of care PD‐1 inhibitors and chemotherapy for early development decision making.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 11, p. 1751, doi. 10.1002/psp4.12917
- By:
- Publication type:
- Article
Modelling and Simulation of the Positive and Negative Syndrome Scale (PANSS) Time Course and Dropout Hazard in Placebo Arms of Schizophrenia Clinical Trials.
- Published in:
- Clinical Pharmacokinetics, 2012, v. 51, n. 4, p. 261, doi. 10.2165/11598460-000000000-00000
- By:
- Publication type:
- Article
Asenapine Pharmacokinetics in Hepatic and Renal Impairment.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 7, p. 471, doi. 10.2165/11590490-000000000-00000
- By:
- Publication type:
- Article
Structural Models Describing Placebo Treatment Effects in Schizophrenia and Other Neuropsychiatric Disorders.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 7, p. 429, doi. 10.2165/11590590-000000000-00000
- By:
- Publication type:
- Article
Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers.
- Published in:
- 2002
- By:
- Publication type:
- journal article
The synthetic pentasaccharide fondaparinux sodium does not interact with oral warfarin.
- Published in:
- 2002
- By:
- Publication type:
- journal article
The pharmacokinetics of fondaparinux sodium in healthy volunteers.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Asenapine pharmacokinetics and tolerability in a pediatric population.
- Published in:
- Drug Design, Development & Therapy, 2018, v. 12, p. 2677, doi. 10.2147/DDDT.S171475
- By:
- Publication type:
- Article
Valproate Reduces the Glucuronidation of Asenapine Without Affecting Asenapine Plasma Concentrations.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 5, p. 757, doi. 10.1177/0091270011404028
- By:
- Publication type:
- Article
Exposure-Response Analysis in Patients With Schizophrenia to Assess the Effect of Asenapine on QTc Prolongation.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 11, p. 1297, doi. 10.1177/0091270009344855
- By:
- Publication type:
- Article
Operating characteristics of stepwise covariate selection in pharmacometric modeling.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2019, v. 46, n. 3, p. 273, doi. 10.1007/s10928-019-09635-6
- By:
- Publication type:
- Article
Modelling and simulation of placebo effect: application to drug development in schizophrenia.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2013, v. 40, n. 3, p. 377, doi. 10.1007/s10928-012-9296-7
- By:
- Publication type:
- Article
Model‐Informed Dose Justifications of Posaconazole in Japanese Patients for Prophylaxis and Treatment Against Fungal Infection.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 4, p. 421, doi. 10.1002/jcph.2180
- By:
- Publication type:
- Article
PROGRAM AIMS TO TAP AFRICA'S POTENTIAL IN PHARMACOMETRICS.
- Published in:
- 2022
- By:
- Publication type:
- Interview
Africa is Biosimulation's Next Frontier.
- Published in:
- Applied Clinical Trials, 2022, v. 31, n. 3, p. 38
- By:
- Publication type:
- Article